Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cel Sci Corp (CVM)  
$1.48 0.06 (4.23%) as of 4:30 Thu 5/2


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 38,620,000
Market Cap: 57.16(M)
Last Volume: 2,036,333 Avg Vol: 2,030,650
52 Week Range: $1.07 - $3.08
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CEL-SCI is a clinical-stage biotechnology company focused on research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. Co. is focused on the development of the following product candidates and technologies: Multikine® (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for the potential treatment of certain head and neck cancers; and Ligand Epitope Antigen Presentation System technology, with CEL-4000 as a product candidate under development for the potential treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 227
  Page 3 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kersten Geert R Chief Executive Officer   •       •      –    2021-03-31 4 A $15.21 $4,335 D/D 285 1,120,797     -
   Talor Eyal Chief Scientific Officer   •       –      –    2021-03-31 4 A $15.21 $2,388 D/D 157 119,405     -
   Talor Eyal Chief Scientific Officer   •       –      –    2020-12-31 4 A $11.66 $2,390 D/D 205 119,248     -
   Prichep Patricia B Senior Vice President   •       –      –    2020-12-31 4 A $11.66 $3,906 D/D 335 206,469     -
   Kersten Geert R Chief Executive Officer   •       •      –    2020-12-31 4 A $11.66 $4,268 D/D 366 1,120,512     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2020-12-31 4 A $11.66 $3,603 D/D 309 115,495     -
   Young Peter R Director   –       •      –    2020-12-11 4 B $14.24 $1,424 D/D 100 25,914 2.31 69%     
   Baillavoine Bruno Jean-Marie Director   –       •      –    2020-11-18 4 B $11.77 $9,416 D/D 800 4,723 2.39 31%     
   Watson Robert Eugene Director   –       •      –    2020-11-18 4 B $11.77 $9,416 D/D 800 3,181 2.39 31%     
   Young Peter R Director   –       •      –    2020-11-17 4 B $11.68 $9,343 D/D 800 25,814 2.39 34%     
   Cipriano John Senior Vice President   •       –      –    2020-11-13 4 S $12.73 $127,290 D/D (10,000) 73,108 -30%     
   Young Peter R Director   –       •      –    2020-11-04 4 B $11.34 $22,670 I/I 2,000 25,014 2.1 67%     
   Young Peter R Director   –       •      –    2020-11-04 4 B $11.39 $11,390 D/D 1,000 23,014 2.39 67%     
   Talor Eyal Chief Scientific Officer   •       –      –    2020-09-30 4 A $12.75 $2,397 D/D 188 119,043     -
   Prichep Patricia B Senior Vice President   •       –      –    2020-09-30 4 A $12.75 $3,787 D/D 297 206,134     -
   Kersten Geert R Chief Executive Officer   •       •      –    2020-09-30 4 A $12.75 $4,271 D/D 335 1,120,146     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2020-09-30 4 A $12.75 $3,506 D/D 275 115,186     -
   Kersten Geert R CEO   •       •      –    2020-06-30 4 A $14.92 $4,267 D/D 286 1,119,811     -
   Zimmerman Daniel H Senior VP, Research   •       –      –    2020-06-30 4 A $14.92 $3,402 D/D 228 114,911     -
   Prichep Patricia B Senior VP, Operations   •       –      –    2020-06-30 4 A $14.92 $3,655 D/D 245 205,837     -
   Talor Eyal Chief Scientific Officer   •       –      –    2020-06-30 4 A $14.92 $2,387 D/D 160 118,855     -
   Kersten Geert R Chief Executive Officer   •       •      –    2020-03-31 4 A $11.54 $4,270 D/D 370 1,119,525     -
   Talor Eyal Chief Scientific Officer   •       –      –    2020-03-31 4 A $11.54 $2,389 D/D 207 118,695     -
   Prichep Patricia B Senior Vice President   •       –      –    2020-03-31 4 A $11.54 $3,658 D/D 317 205,592     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2020-03-31 4 A $11.54 $3,416 D/D 296 114,683     -
  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us